Lorenzo Pierre Insider Trades

Insider Trading History

Track insider trading activity for Lorenzo Pierre. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tempest Therapeutics
Tempest Therapeutics TPST
Corporate Controller
Holding Value $11k 8,477 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.9k 8,477 shares
$2.35
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Corporate Controller
Holding Value $8.99k 8,477 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.99k 8,477 shares
$1.06
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Corporate Controller
Holding Value $8.45k 6,500 shares
Last Trade
Jan 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.4k 6,500 shares
$5.45
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Corporate Controller
Holding Value $6.89k 6,500 shares
Last Trade
Jan 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.89k 6,500 shares
$1.06
$1.06
Millendo Therapeutics
Millendo Therapeutics MLND
Corporate Controller
Holding Value $51.4k 48,535 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$57.9k 54,599 shares
$1.06
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Holding Value $63.1k 48,535 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$869k 54,652 shares
$15.90
$1.30

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up